Physician profile
Casey White
NPI 1871125864
$3,279.68
in general payments reported to CMS, 2019-2025
31 companies · $706 in 2025
The $706 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $364 · 2022: $615 · 2023: $812 · 2024: $782 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,300.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $907.57 | 2022-2025 | Eluvia, General - Pain Management, Jetstream Sc |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $491.23 | 2022-2025 | Relistor |
| Amgen INC. | $288.71 | 2022-2025 | Evenity, Prolia, Prolia |
| Scilex Pharmaceuticals INC. | $200.55 | 2021-2025 | |
| Abbvie INC. | $156.25 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $138.79 | 2021-2024 | Belbuca, Xtampza |
| Angiodynamics, INC. | $121.52 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $113.91 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $94.59 | 2021-2022 | |
| Terumo Medical Corporation | $93.48 | 2024-2025 | Glidewire, Angio-Seal |
| Si-Bone, INC. | $68.09 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $66.43 | 2024-2025 | |
| Bioventus LLC | $58.99 | 2021-2022 | |
| Nevro Corp. | $55.79 | 2023 | Senza |
| Radius Health, INC. | $45.64 | 2023-2025 | Tymlos |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $42.15 | 2025 | |
| Medtronic, INC. | $39.14 | 2025 | Inceptiv |
| Tersera Therapeutics LLC | $38.34 | 2023 | Prialt |
| Alnylam Pharmaceuticals INC. | $37.61 | 2024 | Givlaari |
| Nalu Medical, INC. | $23.18 | 2023 | Nalu Neurostimulation System |
| Painteq LLC | $22.00 | 2022 | |
| Welch Allyn | $21.60 | 2021 | |
| Reprise Biomedical, INC. | $21.44 | 2025 | Miro 3d |
| Redhill Biopharma INC. | $20.72 | 2021 | |
| Averitas Pharma INC. | $19.91 | 2023 | Qutenza |
| Biodelivery Sciences International, INC. | $19.09 | 2021 | |
| Spinal Simplicity, LLC | $18.07 | 2024 | Ha Minuteman G3-R |
| Advanced Oxygen Therapy INC. | $16.93 | 2024 | Topical Oxygen Chamber For Extremities |
| Spr Therapeutics, INC | $15.99 | 2022 | |
| Lilly USA, LLC | $12.69 | 2021 | |
| Genentech USA, INC. | $9.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.